SunAct Cancer Institute and Smita Memorial Hospital Launch South India’s First Centre of Excellence for CAR T-Cell Therapy and Bone Marrow Transplant
Kochi: In a landmark collaboration that bridges visionary science with decades of clinical excellence, SunAct Cancer Institute and Smita Memorial Hospital, founded by the Father of Medical Oncology, Dr. Suresh H. Advani (Padma Shri, Padma Bhushan), today announced the opening of South India’s premier Centre of Excellence in CAR T-Cell Therapy and Bone Marrow Transplantation at Smita Memorial Hospital in Thodupuzha, Idukki district, Kerala.
The Centre was inaugurated on the auspicious occasion of Vishu by Ms. V. Vigneshwari, IAS, District Collector and District Magistrate of Idukki, in the presence of Dr. Advani, SunAct’s co-founders Dr. Vijay Patil and Dr. Ashay Karpe, and other dignitaries from the oncology and healthcare ecosystem.
This collaboration, formalised in March 2025, represents a significant stride in delivering affordable, globally benchmarked cell and gene therapies to India, with a strong emphasis on precision oncology, pediatric care, and access to global clinical trials.
Dr. Suresh H. Advani, Founder, Smita Memorial Hospital, stated: “Over the decades, I have witnessed the evolution of cancer care in India — from limited options to remarkable possibilities. This new Centre of Excellence represents the next frontier: where science, compassion, and collaboration come together to transform patient outcomes. I am proud to see this movement rooted in Kerala, and confident that with SunAct’s scientific leadership, we are building a model for the future of oncology in India.”
Dr. Vijay Patil, Co-Founder, SunAct Cancer Institute, said: “We are honoured to launch the first Centre of Excellence in CAR T-Cell Therapy and Bone Marrow Transplantation in South India. With the visionary guidance of Dr. Suresh Advani, we are committed to making the most advanced cancer therapies — previously only available in elite global centres — both accessible and affordable for Indian patients. This marks a pivotal step in our mission to bring world-class precision oncology to every corner of India.”
Dr. Ashay Karpe, Co-Founder, SunAct Cancer Institute, noted: “This collaboration is a convergence of cutting-edge science and seasoned clinical wisdom. By combining SunAct’s pioneering Cell and Gene Therapies with Dr. Advani’s clinical legacy and Smita Memorial’s infrastructure, we are setting a new benchmark for how cancer should be treated — precise, humane, and accessible.”
